Literature DB >> 24908388

SAME-TT2R 2 score and vitamin K antagonist therapy.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24908388     DOI： 10.1007/s11739-014-1091-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  SAMeTT(2)R(2) does not predict time in therapeutic range of the international normalized ratio in patients attending a high-quality anticoagulation clinic.

Authors:  Jane Skov; Else-Marie Bladbjerg; Mustafa Vakur Bor; Jørgen Gram
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach.

Authors:  Giuseppe Boriani
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

3.  The SAMe-TT₂R₂ score: far from clinical application.

Authors:  Han Zhang; Yanmin Yang; Jun Zhu
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

4.  A prospective validation of the SAME-TT2R 2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin.

Authors:  Daniela Poli; Emilia Antonucci; Sophie Testa; Gregory Yoke Hong Lip
Journal:  Intern Emerg Med       Date:  2014-03-21       Impact factor: 3.397

5.  Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.

Authors:  Gregory Y H Lip; Ken Haguenoer; Christophe Saint-Etienne; Laurent Fauchier
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

6.  Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

Authors:  Stavros Apostolakis; Renee M Sullivan; Brian Olshansky; Gregory Y H Lip
Journal:  Chest       Date:  2013-11       Impact factor: 9.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.